Nucleus accumbens-1 (NAC1), a nuclear factor belonging to the BTB/POZ gene family, has emerging roles in cancer. We report here that NAC1 acts as a negative regulator of cellular senescence in transformed and non-transformed cells, and dysfunction of NAC1 induces senescence and inhibits its oncogenic potential. We show that NAC1 deficiency markedly activates senescence and inhibits proliferation in tumor cells treated with sub-lethal doses of Ȗ-irradiation. In mouse embryonic fibroblasts (MEFs) from NAC1 knockout mice, following infection with a Ras virus, NAC1
Introduction
Cellular senescence is a state in which cells lose the capacity to divide and are irreversibly arrested, and are usually characterized by flattened and enlarged morphology, increased cytoplasmic granularity, and up-regulated activity of senescence-associated ȕ-galactosidase (SA-ȕ-gal) (1, 2).
Senescence can occur after a number of cell divisions or be induced by some stimuli such as oncogenes, radiation, etc. It is now becoming increasingly clear that oncogene-induced senescence (OIS) is one of the critical mechanisms that prevent tumor initiation, development and progression (3), and evasion of cellular senescence constitutes one of the major contributors to tumorigenesis. Cancer cells can also be forced to undergo senescence by therapeutic interventions such as chemotherapeutic agents and radiotherapy. Therapy-induced senescence (TIS) can influence the outcome of treatments (4-6). It is now generally appreciated that evasion of senescence is an important event in tumorigenesis, cancer recurrence, and treatment failure (7-9). Yet, the molecular determinants and mechanisms underlying senescence bypass remain poorly defined.
Nucleus accumbens-1 (NAC1) is a transcription factor repressor that belongs to the BTB/POZ gene family. The highly conserved BTB/POZ domain is required for NAC1 homodimerization, and the homodimer complex participates in regulating a variety of biological functions (10). Overexpression of NAC1 is found in several types of human carcinomas including ovarian cancer, cervical cancer, breast cancer and colon cancer (11-13). It was observed in ovarian cancer patients that the expression level of NAC1 is significantly higher in recurrent post-treatment tumors than pre-treated primary tumors (11, 12, 14) . Also, NACC1, which encodes NAC1, is amplified in many ovarian high-grade serous carcinomas (15) . There are studies reporting that up-regulation of NAC1 promotes tumor cell growth and survival, migration and invasion, and resistance to chemotherapeutic drugs (12, (16) (17) (18) . We recently reported that NAC1 promotes a pro-survival autophagy through the HMGB1-mediated pathway and contributes to
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Author Manuscript Published OnlineFirst on June 4, 2012; DOI: 10.1158/0008-5472.CAN-12-0139 cisplatin resistance (19) . These studies suggest that expression of NAC1 not only bestows oncogenic potential, but may also undermine therapeutic outcomes. Nevertheless, the precise functions of NAC1 in tumor initiation, development and progression are still not well elucidated.
In this study, we have uncovered a novel function of NAC1, which may serve as an important mechanism contributing to its oncogenic potential. We found that NAC1 acts as a negative regulator of cellular senescence, blunting radiation or oncogene-induced cellular senescence through modulation of ¨Np63 expression. NAC1-mediated blunting of senescence enhances tumor cell proliferation, bolsters Ras-mediated transformation of MEFs, and promotes tumor formation. Our study has not only revealed a previously unrecognized function of NAC1 in cancer and its impact on pathogenesis of tumor development and progression, but also identified a new senescence regulator that may be exploited as a potential target for cancer prevention and treatment.
Author Manuscript Published OnlineFirst on June 4, 2012; DOI: 10.1158/0008-5472.CAN-12-0139 SA-ȕ-gal assay. Activity of SA-ȕ-gal was measured as described (20) . Briefly, cells were fixed with 0.2% glutaraldehyde for 15 minutes at room temperature, washed thrice with PBS, and incubated
Materials and Methods
Author Manuscript Published OnlineFirst on June 4, 2012; DOI: 10.1158/0008-5472.CAN-12-0139 at 37 o C overnight in SA-ȕ-gal solution (1mg/ml X-gal, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 150 mM NaCl, and 2 mM MgCl 2 in PBS at pH 6.0). Blue stained senescent cells were counted under a light microscope.
Cell proliferation assay. Cell proliferation was measured using a BrdU Cell Proliferation Assay Kit rinsed with PBS and lysed in 300 ȝl 1× reporter passive lysis buffer. Lysates were used directly for luciferase activity assay by using the Dural-Luciferase Reporter Assay System (Promega, Madison, USA) and luminometer (Pekin Elmer).
Production and infection retrovirus Constructs. A retrovirus carrying the NAC1-V5 expression vector
Author Manuscript Published OnlineFirst on June 4, 2012; DOI: 10.1158/0008-5472. was constructed by cloning the entire coding sequence of NAC1 into the pWZL-Hygro retroviral vector.
pBabe-RasV12 was constructed by sub-cloning a cDNA encoding human H-Ras 12V mutant into pBabe vector. pDCR-vector and pDCR-RasV12 were generous gifts from Dr. Channing Der (University of North Carolina School of Medicine). Packaging cell line 293T was used for retrovirus production.
MEFs were infected with viruses for 48 hours, followed by selection with antibiotics. For infection with pWZL or pWZL-NAC1, pBabe or pBabe-RasV12, transduced cells were selected with hygromycine (for immortal cells, 7.5ȝg/ml for 2 weeks; for primary cells, 5ȝg/ml for 3 days); for infection with pDCR or pDCR-RasV12, transduced cells were selected with G418 (500ȝg/ml). These observations, which suggest a possible role for NAC1 in reducing replicative senescence, prompted us to investigate whether the function or expression of NAC1 indeed impacts induction of cellular senescence. Because activation of DNA damage response is a proven cause for induction of senescence (22), we used a sub-lethal dose of Ȗ-irradiation (6 Gy) to induce senescence. As shown in and Hela/N130 cells subjected to Ȗ-irradiation became spread and flattened, and these cells had a significant increase in the populations with SA-ȕ-gal staining (Fig. 1A) ; by contrast, these alterations were not observed in the cells without expression of the NAC1 dominant negative mutant (Fig. 1A) . In the cells with a dysfunctional NAC1, there was also an increase in the amount of p21 (Fig. 1B) .
Inactivation of NAC1 also significantly enhanced the proliferation-inhibitory (Fig. 1C) and the colony formation-inhibitory effects (Fig. 1D) , and caused a G2/M cell cycle arrest (Fig. 1E) , suggesting that senescence occurs in G2/M phase. To ascertain the inhibitory effect of NAC1 on senescence, we knocked down the expression of this protein in A2780 cells, followed by treatment with 4 Gy of Ȗ- irradiation. Multiple NAC1-targeted siRNA sequences were tested to confirm the specificity of the effect of NAC1. Fig. 1B shows that two NAC1-targeted siRNA sequences selected from several active sequences had similar effects on p21 expression. Silencing of NAC1 expression in A2780 cells showed similar effects to the dominant mutant on cellular morphology, SA-ȕ-gal activity, p21, cell proliferation, colony formation, and cell cycle progression (Fig. 1A-D) . The enforced proliferative arrest seen in the NAC1-deficient cells did not appear to be a consequence of activation of apoptosis, as there was no significant Annexin V staining in those cells (Fig. S2) . The role of p21 in senescence induction mediated by NAC1 deficiency was further demonstrated when p21 expression was silenced (Fig. S3) .
Consistently, the effects of NAC1 function on senescence induction were recapitulated in the tumor xenografts of Hela/N130 cells grown in mice (Fig. 1F) . Taken together, all of the above evidence point to a role for NAC1 as a negative regulator of cellular senescence. (23), suggesting that p53 is not necessary for senescence caused by NAC1 dysfunction. To test this hypothesis, we compared SA-ȕ-gal activity, cell proliferation, and p21 level in the wild-type p53-containing A2780 cells when NAC1 was knocked down or both of NAC1 and p53 were knocked down, followed by Ȗ-irradiation treatment. Fig. 2 shows that silencing of p53 did not abrogate the effects of NAC1 depletion on senescence ( Fig. 2A-Fig. 2C ), implying that induction of senescence caused by NAC1 inhibition does not depend on p53 function.
Induction of senescence by inhibiting NAC1 is independent of p53 status

ǻNp63 is required for the NAC1-mediated senescence evasion
As p53 was not required for up-regulation of p21 caused by NAC1 deficiency, we next examined whether p63, belonging to the p53 protein family, was involved. ǻNp63, a predominant p63 isoform known to antagonize p53 (24), can bind to the promoter of p21, inhibiting its transcription (25). We found that the expression of ǻNp63 protein was markedly down-regulated in cells with deficiency of NAC1 following treatment with Ȗ-irradiation (Fig. 3A) . By contrast, there were no changes in the expression of TAp63 protein, another isoform of p63 that has similar functions to p53 (Fig. 3A) , suggesting that the effect of NAC1 on ǻNp63 expression is specific. To determine whether ǻNp63 is indeed required for the NAC1-mediated suppression of senescence, we silenced the expression of ǻNp63 in cancer cells with active NAC1 function, followed by Ȗ-irradiation. Silencing of ǻNp63 expression either in SKOV3/N130 or Hela/N130 cells cultured in the presence of doxycycline, or in A2780 cells, led to induction of cellular senescence, (Fig. 3B -Fig. 3D ). The role of ǻNp63 in NAC1-mediated evasion of senescence was further verified by over-expressing ǻNp63 in NAC1-deficient cells.
As shown in Fig. 3E and Fig. 3F , ectopic expression of ǻNp63 in SKOV3/N130 or Hela/N130 cells with inactivation of NAC1 or in A2780 cells with silencing of NAC1 significantly blunted the activation of senescence caused by Ȗ-irradiation ( Fig. 3E and Fig. 3F ). These results indicate that ǻNp63 is a necessary mediator of NAC1-mediated bypass of senescence, and that up-regulation of p21 may be responsible for induction of senescence resulting from dysfunction of NAC1. Expression of p15, p16 and p18, which are also known to play roles in senescence, did not show differences between the NAC1-activated and -inactivated cells following irradiation treatment (Fig. S4) 
Transcription of ǻNp63 is modulated by NAC1
Since NAC1 was shown to control cellular senescence through ǻNp63 (Fig. 3) , next we sought to address whether the functional status of NAC1 plays a role in modulating transcription of ǻNp63 under stressful conditions, as NAC1 is a transcription co-factor. qRT-PCR analysis showed that inactivation or silencing of NAC1 did not affect the expression of ǻNp63 mRNA in cells without exposure to Ȗ- irradiation; however, NAC1-deficient cells had ~3-fold decreases in ǻNp63 mRNA following treatment with Ȗ-irradiation, as compared with the cells with an intact NAC1 (Fig. 4A) . To obtain more direct evidence for transcriptional regulation of ǻNp63 by NAC1, we performed a reporter gene assay. Cells with or without an intact NAC1 were transiently transfected with a ǻNp63 promoter-luciferase construct, and the activity of the reporter gene (luciferase activity) was measured 48 hours later. Fig. 4B shows that as compared with the cells with an intact NAC1 function, the cells lacking NAC1 function showed a 5-to 7-fold reduction in the ǻNp63 promoter activity. Consistently, the expressions of ǻNp63 mRNA, the promoter activity, and protein level were similarly down-regulated in NAC1 -/-mouse embryonic fibroblasts (MEFs) transduced with Ras V12 , as compared with NAC1 +/+ MEFs ( Fig. S5 and Fig. 5D ). These results indicate that NAC1 plays a critical role in promoting the transcription of ǻNp63 under stress conditions.
NAC1 plays an essential in blunting Ras-induced senescence in primary MEFs
To explore the role of NAC1-mediated reduction of senescence in oncogenesis, we assessed the effect of NAC1 on oncogene-induced senescence in our genetically engineered primary MEFs that are NAC1 . The knockout cells were confirmed by genotyping (Fig. S6) . Unexpectedly, we observed a low level of senescence in the H-Ras V12 -infected NAC1 +/+ MEFs ( Fig. 5C and Fig. 5D ), likely due to a low activity of the Ras variant used, or due to spontaneous immortalization of the MEFs, which would then lead to sensitivity to transformation by Ras. By contrast, when H-Ras V12 was transduced into NAC1 -/-MEFs, the growth of NAC1 -/-cells was arrested (Fig. 5A ), colony formation of NAC1 -/-cells was inhibited (Fig. 5B) , 80% of the NAC1 -/-cells were SA-ȕ-gal positive (Fig. 5C ), p21 levels were up-regulated and ǻNp63 was down-regulated ( Fig. 5D ), indicating that these NAC1 -/-MEFs were undergoing robust senescence. Similar to NAC1 +/+ MEFs, these H-Ras V12 -activated senescence
on January 6, 2018. © 2012 American Association for Cancer cancerres.aacrjournals.org Downloaded from responses were also significantly attenuated in NAC1 +/-MEFs (Fig. 5A-D (Fig. 6D) . Moreover, HE staining of the tumor specimens showed that the morphology of the Ras 
Discussion
The current study uncovers NAC1 as a new regulator of cellular senescence. We reveal that the tumor recurrence-associated gene NAC1 negatively regulates senescence, and that blunting of senescence driven by NAC1 may represent an essential molecular function contributing to the oncogenic potential of this nuclear factor. Our results show that under stressful conditions, loss of NAC1 function restores senescence response in tumor cells (Fig. 1) and MEFs (Fig. 5 and Fig. 6 ). More importantly, we demonstrate both in vitro and in vivo that blunting of cellular senescence by NAC1 cooperates with Ras to promote cellular transformation and tumor development (Fig. 5 and Fig. 6 ). Although it has been shown that overexpression of NAC1 is linked to cancer development, recurrence, and resistance to therapy, the exact roles that this nuclear factor may play are largely unknown. Thus, our findings provide new insights into the functions of NAC1 in tumor pathogenesis.
Senescence response is often accompanied by activation of tumor-suppressor network such as p53 and pRB pathways, which prevent aberrant and unlimited proliferation of tumor cells (26).
Therefore, OIS is believed to serve as an initial barrier in tumor development. p53 has been shown to be involved in activation of cellular senescence under various circumstances (27); however, in this study, induction of senescence caused by loss of NAC1 appears to be independent of p53, as the cells without a functional p53 retain senescence response when NAC1 is inactivated or depleted (Fig. 2) . p53-independent induction of senescence was also observed by others (28). NAC1-mediated suppression of senescence, however, requires ǻNp63, a p53 homolog, as even when NAC1 is intact, knockdown of ǻNp63 abolishes bypass of senescence, and when NAC1 is defective, ectopic expression of ǻNp63 blocks induction of the senescence (Fig. 3) . ǻNp63 plays a critical role in bypassing cellular senescence (29, 30) , and is frequently overexpressed in various types of tumor cells (31-33). Indeed, when senescence is activated in the NAC1-deficient cells subjected to radiation or oncogenic stress, ǻNp63
Research. 2012; DOI: 10.1158/0008-5472.CAN-12-0139 protein is down-regulated (Fig. 3) , suggesting that suppression of senescence by NAC1 is mediated via ǻNp63, which inhibits the expression of p21. We further show that NAC1 modulates transcription of ǻNp63 in stressed cells (Fig. 4 and Fig. S5 ). However, in ChIP assays we failed to enrich significant promoter sequences including p63. There are at least two explanations for this finding. First, it is likely that the NAC1 antibodies available are not suitable for ChIP. Alternatively, NAC1 does not directly bind to DNA and thus NAC1 regulates transcriptional activity through binding to and modulating the transcription functions of its co-factor(s) that directly interact with specific gene promoters or enhancers.
Therefore, the precise mechanism by which NAC1 regulates transcription of ǻNp63 remains to be delineated. Our experiments show that the changes in ǻNp63 protein (Fig. 3) were larger than the changes in ǻNp63 mRNA (Fig. 4) , suggesting that post-transcriptional regulation of ǻNp63 may also be involved in changes of the level of this protein. Although it was reported that degradation of ǻNp63 protein is promoted by stress such as DNA damage and oncogene activation (29, 34), in our pulse-chase experiments we found that loss of NAC1 barely affects the turnover of ǻNp63 in the stressed cells (data not shown). Thus, it appears that NAC1 promotes bypass of cellular senescence mainly via modulating transcription of ǻNp63 under stressful conditions.
In our experiments, the senescence induction was low in the Ras-transduced wild-type MEFs (Fig. 5) , which could be due to that these MEFs had undergone spontaneous immortalization, or the activity level of the Ras variant used in this study was low, and these may actually lead to sensitivity to transformation by Ras in NAC1 -/-MEFs. We found that blunting of cellular senescence mediated by NAC1 plays a crucial role in tumorigenesis, and that NAC1-deficient cells are much less transformed and tumorigenic in the presence of oncogene Ras. However, absence of NAC1 does not seem to completely reverse the effects of Ras, suggesting that the NAC1-mediated bypass of senescence, although impactful, is only one of the components that drive tumor initiation and development. Our
Research. 2012; DOI: 10.1158/0008-5472.CAN-12-0139 observation raises the possibility that targeting NAC1 to restore senescence response may be explored as a potential new strategy for cancer preventive. In addition, it is likely that the NAC1-mediated blunting of senescence may also influence other facets of cancer, such as tumor dormancy, response to therapeutic intervention, metastasis, etc.. Exploring the effects of NAC1-mediated senescence on these features of cancer might shed significant new light on the importance of NAC1 and senescence in cancer prevention and treatment. In addition, NAC1 has been demonstrated to be associated with Nanog in a protein complex that is necessary for maintaining the stemness of mouse embryonic stem cells (35, 36) .
Nanog is capable of preventing terminal differentiation of embryonic stem cells and sustaining their pluripotency through a protein network involving NAC1 (37). The validated interaction of NAC1 with Nanog (37), as part of a multi-member family necessary for maintaining the stemness of mouse embryonic stem cells, implies that NAC1 function may play a role in preventing or determining the terminal differentiation of cells. It would be interesting to investigate whether or not this function of NAC1 in stem cells is associated with its effect on cellular senescence.
In summary, the main finding in this study is that we identify NAC1 as a negative regulator of cellular senescence, and blunting of senescence caused by NAC1, which is mediated through ǻNp63, plays an important role in promoting tumorigenesis. The identification of NAC1 as a senescence regulator, along with the pathways involved, should help further understand the molecular and cellular functions of this nuclear factor in cancer, and may provide a potential target for cancer prevention and treatment.
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